美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Estrella Immunopharma

1.75

+0.13958.66%

盤後：1.68-0.0700-4.00%19:24 EDT

成交量：42.13萬

成交額：73.09萬

市值：6,486.48萬

市盈率：-5.29

高：1.90

開：1.52

低：1.52

收：1.61

52周最高：1.90

52周最低：0.6300

股本：3,706.56萬

流通股本：1,098.55萬

量比：1.30

換手率：3.84%

股息：- -

股息率：- -

每股收益(TTM):-0.3309

每股收益(LYR):-0.1212

淨資產收益率：-268.50%

總資產收益率：-100.93%

市淨率：-10.64

市盈率(LYR):-14.43

資料載入中...

總覽公司新聞公告

Estrella Immunopharma, Inc.盤中異動早盤股價大跌6.37%報0.880美元

Estrella Immunopharma, Inc.盤中異動大幅上漲5.87%

Estrella Immunopharma, Inc.盤中異動股價大跌7.07%報0.920美元

Estrella Immunopharma, Inc.盤中異動股價大漲7.75%報1.004美元

Estrella Immunopharma, Inc.盤中異動早盤大幅下跌5.20%

Estrella Immunopharma, Inc.盤中異動大幅拉昇6.25%報1.020美元

Estrella Immunopharma, Inc.盤中異動早盤股價大漲5.38%報1.050美元

Estrella Immunopharma, Inc.盤中異動股價大漲6.21%

Estrella Immunopharma, Inc.盤中異動早盤大幅下挫5.82%

Estrella Immunopharma, Inc.盤中異動早盤股價大跌5.66%報1.00美元

Estrella Immunopharma, Inc.盤中異動早盤大幅下挫7.06%

Estrella Immunopharma, Inc.盤中異動早盤股價大漲5.49%報0.880美元

Estrella Immunopharma, Inc.盤中異動下午盤快速跳水5.06%報0.959美元

Estrella Immunopharma, Inc.盤中異動早盤快速上漲6.19%報1.030美元

Estrella Immunopharma, Inc.盤中異動早盤股價大漲6.12%

Estrella Immunopharma, Inc.盤中異動急速上漲6.37%報1.000美元

Estrella Immunopharma, Inc.盤中異動早盤急速跳水5.05%報0.940美元

Estrella Immunopharma, Inc.盤中異動急速下挫8.58%

Estrella Immunopharma, Inc.盤中異動早盤股價大跌6.70%

Estrella Immunopharma, Inc.盤中異動股價大漲5.43%報1.17美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ESLA/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ESLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLA\",,,,,undefined,":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":1.75,"timestamp":1760731200000,"preClose":1.6105,"halted":0,"volume":421333,"hourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.75,"latestTime":"19:24 EDT","volume":312,"amount":529.0838,"timestamp":1760743486136},"delay":0,"floatShares":10985451,"shares":37065589,"eps":-0.330901,"marketStatus":"休市中","change":0.1395,"latestTime":"10-17 16:00:00 EDT","open":1.52,"high":1.9,"low":1.52,"amount":730939.8222577,"amplitude":0.235952,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.330901,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.6105,"preHourTrading":{"tag":"盘前","latestPrice":1.53,"preClose":1.63,"latestTime":"08:53 EDT","volume":929,"amount":1426.8000049999998,"timestamp":1760705607812},"postHourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.75,"latestTime":"19:24 EDT","volume":312,"amount":529.0838,"timestamp":1760743486136},"volumeRatio":1.2977341176373582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLA\",,,,,undefined,":{"symbol":"ESLA","floatShares":10985451,"roa":"-100.93%","roe":"-268.50%","lyrEps":-0.121236,"volumeRatio":1.2977341176373582,"shares":37065589,"dividePrice":0,"high":1.9,"amplitude":0.235952,"preClose":1.6105,"low":1.52,"week52Low":0.63,"pbRate":"-10.64","week52High":1.9,"institutionHeld":0,"latestPrice":1.75,"eps":-0.330901,"divideRate":0,"volume":421333,"delay":0,"ttmEps":-0.330901,"open":1.52,"prevYearClose":1.2,"prevWeekClose":1.29,"prevMonthClose":1.15,"prevQuarterClose":1.15,"fiveDayClose":1.29,"twentyDayClose":1.11,"sixtyDayClose":0.9495},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ESLA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"ESLA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ESLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ESLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1740024000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ESLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ESLA","date":"2025-10-17","current":-5.288591,"percent":0.268041,"low":-10.568666,"twenty":-5.357776,"median":-4.421106,"eighty":-3.652349,"high":-2.54331,"avg":-4.606552,"sd":1.23961,"marketCap":59694131},"quantilePoints":[{"date":"2023-10-13","current":-4.972461,"twenty":-6.796753,"median":-5.384194,"eighty":-5.200498,"marketCap":55265934},{"date":"2023-10-20","current":-4.346628,"twenty":-5.624899,"median":-4.845774,"eighty":-4.503973,"marketCap":48310170},{"date":"2023-10-27","current":-4.814103,"twenty":-5.358857,"median":-4.766595,"eighty":-4.395592,"marketCap":53505872},{"date":"2023-11-03","current":-4.877446,"twenty":-5.358857,"median":-4.877446,"eighty":-4.546793,"marketCap":54209897},{"date":"2023-11-10","current":-4.085653,"twenty":-5.257507,"median":-4.829938,"eighty":-4.367404,"marketCap":45409589},{"date":"2023-11-17","current":-3.800607,"twenty":-5.219501,"median":-4.560729,"eighty":-4.142662,"marketCap":42241478},{"date":"2023-11-24","current":-4.914497,"twenty":-5.067477,"median":-4.560729,"eighty":-4.117325,"marketCap":49633737},{"date":"2023-12-01","current":-5.785861,"twenty":-5.257507,"median":-4.829938,"eighty":-4.244012,"marketCap":58434045},{"date":"2023-12-08","current":-4.18255,"twenty":-5.193333,"median":-4.719087,"eighty":-4.244012,"marketCap":42241478},{"date":"2023-12-15","current":-4.356823,"twenty":-5.067477,"median":-4.653087,"eighty":-4.244012,"marketCap":44001540},{"date":"2023-12-22","current":-4.321969,"twenty":-5.053915,"median":-4.560729,"eighty":-4.244012,"marketCap":43649527},{"date":"2023-12-29","current":-4.008277,"twenty":-5.005043,"median":-4.502348,"eighty":-4.203463,"marketCap":40481416},{"date":"2024-01-05","current":-4.043132,"twenty":-4.967839,"median":-4.461387,"eighty":-4.18255,"marketCap":40833429},{"date":"2024-01-12","current":-3.520313,"twenty":-4.949351,"median":-4.397024,"eighty":-4.086666,"marketCap":35553244},{"date":"2024-01-19","current":-3.555168,"twenty":-4.949351,"median":-4.37517,"eighty":-4.043132,"marketCap":35905256},{"date":"2024-01-26","current":-4.217405,"twenty":-4.914497,"median":-4.391678,"eighty":-4.043132,"marketCap":42593490},{"date":"2024-02-02","current":-4.217405,"twenty":-4.914497,"median":-4.356823,"eighty":-4.022309,"marketCap":42593490},{"date":"2024-02-09","current":-4.008626,"twenty":-4.879642,"median":-4.356475,"eighty":-4.008626,"marketCap":40484936},{"date":"2024-02-16","current":-3.79915,"twenty":-4.877446,"median":-4.314662,"eighty":-4.008277,"marketCap":38369342},{"date":"2024-02-23","current":-4.421106,"twenty":-4.852108,"median":-4.351551,"eighty":-4.008277,"marketCap":36976978},{"date":"2024-03-01","current":-4.46488,"twenty":-4.845774,"median":-4.356823,"eighty":-4.008556,"marketCap":37343087},{"date":"2024-03-08","current":-4.683308,"twenty":-4.845774,"median":-4.37517,"eighty":-4.008626,"marketCap":39169969},{"date":"2024-03-15","current":-4.508653,"twenty":-4.845774,"median":-4.391678,"eighty":-4.019572,"marketCap":37709196},{"date":"2024-03-22","current":-4.727519,"twenty":-4.845774,"median":-4.421106,"eighty":-4.038967,"marketCap":39539739},{"date":"2024-03-28","current":-5.471666,"twenty":-4.878324,"median":-4.421106,"eighty":-4.043132,"marketCap":45763587},{"date":"2024-04-05","current":-4.990159,"twenty":-4.946386,"median":-4.434042,"eighty":-4.068645,"marketCap":41736391},{"date":"2024-04-12","current":-4.771293,"twenty":-4.947572,"median":-4.461387,"eighty":-4.088693,"marketCap":39905848},{"date":"2024-04-19","current":-4.508653,"twenty":-4.946386,"median":-4.46488,"eighty":-4.106683,"marketCap":37709196},{"date":"2024-04-26","current":-4.552426,"twenty":-4.946123,"median":-4.508653,"eighty":-4.135548,"marketCap":38075304},{"date":"2024-05-03","current":-4.604954,"twenty":-4.927077,"median":-4.543309,"eighty":-4.168608,"marketCap":38514635},{"date":"2024-05-10","current":-4.683746,"twenty":-4.914497,"median":-4.525981,"eighty":-4.18255,"marketCap":39173630},{"date":"2024-05-17","current":-6.309978,"twenty":-4.927077,"median":-4.552426,"eighty":-4.18255,"marketCap":38441413},{"date":"2024-05-24","current":-6.009503,"twenty":-4.949351,"median":-4.552645,"eighty":-4.18255,"marketCap":36610870},{"date":"2024-05-31","current":-5.254478,"twenty":-5.016423,"median":-4.56334,"eighty":-4.196492,"marketCap":32011137},{"date":"2024-06-07","current":-5.573329,"twenty":-5.126143,"median":-4.595762,"eighty":-4.217405,"marketCap":33953631},{"date":"2024-06-14","current":-5.672448,"twenty":-5.245388,"median":-4.604954,"eighty":-4.217405,"marketCap":34557478},{"date":"2024-06-21","current":-5.254478,"twenty":-5.254478,"median":-4.639973,"eighty":-4.217405,"marketCap":32011137},{"date":"2024-06-28","current":-5.553028,"twenty":-5.257507,"median":-4.639973,"eighty":-4.217405,"marketCap":33829952},{"date":"2024-07-05","current":-6.836793,"twenty":-5.380881,"median":-4.661859,"eighty":-4.222726,"marketCap":41650855},{"date":"2024-07-12","current":-8.120557,"twenty":-5.46684,"median":-4.674942,"eighty":-4.245731,"marketCap":49471758},{"date":"2024-07-15","current":-8.478817,"twenty":-5.484657,"median":-4.679369,"eighty":-4.24745,"marketCap":51654336},{"date":"2024-08-02","current":-10.568666,"twenty":-5.500483,"median":-4.681339,"eighty":-4.24917,"marketCap":64386038},{"date":"2024-08-09","current":-8.299687,"twenty":-5.526159,"median":-4.683746,"eighty":-4.266453,"marketCap":50563047},{"date":"2024-08-16","current":-8.419107,"twenty":-5.589093,"median":-4.694558,"eighty":-4.282332,"marketCap":51290573},{"date":"2024-08-23","current":-7.881717,"twenty":-5.717813,"median":-4.727519,"eighty":-4.286974,"marketCap":48016706},{"date":"2024-08-30","current":-6.896503,"twenty":-6.017985,"median":-4.738462,"eighty":-4.287114,"marketCap":42014618},{"date":"2024-09-06","current":-6.329258,"twenty":-6.201587,"median":-4.792698,"eighty":-4.288183,"marketCap":38558870},{"date":"2024-09-13","current":-7.045778,"twenty":-6.309738,"median":-4.815066,"eighty":-4.296814,"marketCap":42924025},{"date":"2024-09-20","current":-5.76261,"twenty":-6.309738,"median":-4.815066,"eighty":-4.313201,"marketCap":35106760},{"date":"2024-09-27","current":-5.791271,"twenty":-6.293445,"median":-4.845774,"eighty":-4.331833,"marketCap":35281366},{"date":"2024-10-04","current":-5.494176,"twenty":-6.293445,"median":-4.868142,"eighty":-4.350567,"marketCap":40171894},{"date":"2024-10-11","current":-4.148845,"twenty":-6.216784,"median":-4.858839,"eighty":-4.350567,"marketCap":30335209},{"date":"2024-10-18","current":-4.157755,"twenty":-6.122441,"median":-4.845774,"eighty":-4.288183,"marketCap":30400352},{"date":"2024-10-25","current":-4.212202,"twenty":-6.099645,"median":-4.815066,"eighty":-4.286905,"marketCap":30798452},{"date":"2024-10-31","current":-4.032032,"twenty":-6.085858,"median":-4.815066,"eighty":-4.286835,"marketCap":29481103},{"date":"2024-11-08","current":-3.964716,"twenty":-6.030708,"median":-4.792698,"eighty":-4.245731,"marketCap":28988907},{"date":"2024-11-15","current":-4.157755,"twenty":-6.026467,"median":-4.727519,"eighty":-4.217405,"marketCap":30400352},{"date":"2024-11-22","current":-3.652759,"twenty":-6.001802,"median":-4.723303,"eighty":-4.18255,"marketCap":32209897},{"date":"2024-11-29","current":-4.656782,"twenty":-5.970998,"median":-4.694558,"eighty":-4.18255,"marketCap":41063331},{"date":"2024-12-06","current":-5.005528,"twenty":-5.961427,"median":-4.719087,"eighty":-4.18255,"marketCap":44138559},{"date":"2024-12-13","current":-5.066661,"twenty":-5.907942,"median":-4.727519,"eighty":-4.18255,"marketCap":44677628},{"date":"2024-12-20","current":-4.513181,"twenty":-5.895445,"median":-4.727519,"eighty":-4.18255,"marketCap":39797061},{"date":"2024-12-27","current":-4.800383,"twenty":-5.891211,"median":-4.759354,"eighty":-4.202312,"marketCap":42329601},{"date":"2025-01-03","current":-4.595649,"twenty":-5.831182,"median":-4.759354,"eighty":-4.210222,"marketCap":40524262},{"date":"2025-01-10","current":-4.55421,"twenty":-5.791868,"median":-4.759354,"eighty":-4.214283,"marketCap":40158853},{"date":"2025-01-17","current":-4.808589,"twenty":-5.791868,"median":-4.765324,"eighty":-4.217405,"marketCap":42401960},{"date":"2025-01-24","current":-4.841412,"twenty":-5.791749,"median":-4.765324,"eighty":-4.217405,"marketCap":42691393},{"date":"2025-01-31","current":-4.595239,"twenty":-5.790189,"median":-4.759354,"eighty":-4.217405,"marketCap":40520644},{"date":"2025-02-07","current":-4.718325,"twenty":-5.781211,"median":-4.75438,"eighty":-4.222726,"marketCap":41606019},{"date":"2025-02-14","current":-4.636268,"twenty":-5.75842,"median":-4.727519,"eighty":-4.245731,"marketCap":40882436},{"date":"2025-02-21","current":-6.113309,"twenty":-5.785861,"median":-4.749406,"eighty":-4.252608,"marketCap":53906929},{"date":"2025-02-28","current":-3.938776,"twenty":-5.785861,"median":-4.75438,"eighty":-4.252608,"marketCap":34731981},{"date":"2025-03-07","current":-4.061863,"twenty":-5.76261,"median":-4.727519,"eighty":-4.217405,"marketCap":35817355},{"date":"2025-03-14","current":-4.184949,"twenty":-5.741662,"median":-4.718911,"eighty":-4.212202,"marketCap":36902729},{"date":"2025-03-21","current":-3.781635,"twenty":-5.692164,"median":-4.717095,"eighty":-4.184949,"marketCap":33346319},{"date":"2025-03-28","current":-3.800136,"twenty":-5.672448,"median":-4.683746,"eighty":-4.18255,"marketCap":33646606},{"date":"2025-04-04","current":-3.839558,"twenty":-5.66199,"median":-4.683746,"eighty":-4.157755,"marketCap":33995653},{"date":"2025-04-11","current":-3.717019,"twenty":-5.653341,"median":-4.678332,"eighty":-4.145266,"marketCap":32910685},{"date":"2025-04-17","current":-3.41639,"twenty":-5.652863,"median":-4.673905,"eighty":-4.117991,"marketCap":30248898},{"date":"2025-04-25","current":-3.921251,"twenty":-5.627318,"median":-4.661859,"eighty":-4.100129,"marketCap":34718965},{"date":"2025-05-02","current":-4.656485,"twenty":-5.620962,"median":-4.656633,"eighty":-4.100129,"marketCap":41228771},{"date":"2025-05-09","current":-4.738178,"twenty":-5.614383,"median":-4.656485,"eighty":-4.103875,"marketCap":41952083},{"date":"2025-05-16","current":-3.800286,"twenty":-5.606051,"median":-4.639973,"eighty":-4.100129,"marketCap":33999270},{"date":"2025-05-23","current":-3.448008,"twenty":-5.579539,"median":-4.636268,"eighty":-4.061863,"marketCap":36165589},{"date":"2025-05-30","current":-4.166329,"twenty":-5.561148,"median":-4.636268,"eighty":-4.061535,"marketCap":36888900},{"date":"2025-06-06","current":-4.329714,"twenty":-5.553028,"median":-4.610297,"eighty":-4.04971,"marketCap":38335524},{"date":"2025-06-13","current":-4.125482,"twenty":-5.553028,"median":-4.595762,"eighty":-4.04971,"marketCap":36527244},{"date":"2025-06-20","current":-3.80443,"twenty":-5.54228,"median":-4.595239,"eighty":-4.043395,"marketCap":33684629},{"date":"2025-06-27","current":-3.241128,"twenty":-5.526159,"median":-4.580844,"eighty":-4.026198,"marketCap":33995653},{"date":"2025-07-03","current":-3.034247,"twenty":-5.524015,"median":-4.570132,"eighty":-4.008754,"marketCap":31825718},{"date":"2025-07-11","current":-3.185615,"twenty":-5.515089,"median":-4.55421,"eighty":-4.008277,"marketCap":33413387},{"date":"2025-07-18","current":-2.827711,"twenty":-5.513197,"median":-4.552645,"eighty":-3.966457,"marketCap":29659399},{"date":"2025-07-25","current":-3.273884,"twenty":-5.50782,"median":-4.552426,"eighty":-3.959029,"marketCap":34339226},{"date":"2025-08-01","current":-2.896327,"twenty":-5.494176,"median":-4.538015,"eighty":-3.922458,"marketCap":30379094},{"date":"2025-08-08","current":-2.903223,"twenty":-5.494004,"median":-4.513181,"eighty":-3.885066,"marketCap":30451425},{"date":"2025-08-15","current":-2.639426,"twenty":-5.488988,"median":-4.510917,"eighty":-3.835115,"marketCap":31891232},{"date":"2025-08-22","current":-2.699552,"twenty":-5.46684,"median":-4.508653,"eighty":-3.80035,"marketCap":32617718},{"date":"2025-08-29","current":-2.944966,"twenty":-5.444751,"median":-4.482671,"eighty":-3.7826,"marketCap":35582965},{"date":"2025-09-05","current":-3.313087,"twenty":-5.433608,"median":-4.465996,"eighty":-3.769203,"marketCap":40030836},{"date":"2025-09-12","current":-3.19038,"twenty":-5.427893,"median":-4.461387,"eighty":-3.733631,"marketCap":38548212},{"date":"2025-09-19","current":-3.435793,"twenty":-5.415817,"median":-4.461387,"eighty":-3.662784,"marketCap":41513459},{"date":"2025-09-26","current":-3.527824,"twenty":-5.384194,"median":-4.434042,"eighty":-3.638873,"marketCap":42625427},{"date":"2025-10-03","current":-4.049328,"twenty":-5.384119,"median":-4.421106,"eighty":-3.638873,"marketCap":48926577},{"date":"2025-10-10","current":-3.773237,"twenty":-5.367927,"median":-4.421106,"eighty":-3.650531,"marketCap":45590674},{"date":"2025-10-17","current":-4.940487,"twenty":-5.357776,"median":-4.421106,"eighty":-3.652349,"marketCap":59694131}],"updateTime":1760853165434},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ESLA\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546774745","title":"Estrella Immunopharma, Inc.盤中異動 早盤股價大跌6.37%報0.880美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546774745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546774745?lang=zh_tw&edition=fundamental","pubTime":"2025-06-27 23:12","pubTimestamp":1751037121,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日23时12分，Estrella Immunopharma, Inc.股票出现波动，股价大幅下跌6.37%。截至发稿，该股报0.880美元/股，成交量1078股，换手率0.00%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627231201a4c180b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627231201a4c180b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2545231548","title":"Estrella Immunopharma, Inc.盤中異動 大幅上漲5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545231548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545231548?lang=zh_tw&edition=fundamental","pubTime":"2025-06-24 23:42","pubTimestamp":1750779757,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日23时42分，Estrella Immunopharma, Inc.股票出现波动，股价大幅拉升5.87%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624234238a71b8027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624234238a71b8027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2545101034","title":"Estrella Immunopharma, Inc.盤中異動 股價大跌7.07%報0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545101034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545101034?lang=zh_tw&edition=fundamental","pubTime":"2025-06-23 21:32","pubTimestamp":1750685572,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时32分，Estrella Immunopharma, Inc.股票出现波动，股价快速下挫7.07%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Impact Biomedical, Inc.、Cidara Therapeutics, Inc.、Indaptus Therapeutics, Inc.涨幅较大，Indaptus Therapeutics, Inc.、Impact Biomedical, Inc.、Nucana Plc较为活跃，换手率分别为900.47%、898.95%、200.36%，振幅较大的相关个股有Impact Biomedical, Inc.、Skye Bioscience, Inc.、Indaptus Therapeutics, Inc.，振幅分别为30.38%、19.44%、16.55%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213252a718f170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213252a718f170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2545177590","title":"Estrella Immunopharma, Inc.盤中異動 股價大漲7.75%報1.004美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545177590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545177590?lang=zh_tw&edition=fundamental","pubTime":"2025-06-21 02:50","pubTimestamp":1750445456,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日02时50分，Estrella Immunopharma, Inc.股票出现波动，股价快速拉升7.75%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062102505697884b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062102505697884b18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2544966199","title":"Estrella Immunopharma, Inc.盤中異動 早盤大幅下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544966199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544966199?lang=zh_tw&edition=fundamental","pubTime":"2025-06-17 22:45","pubTimestamp":1750171552,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日22时45分，Estrella Immunopharma, Inc.股票出现异动，股价急速下跌5.20%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617224552a70e8e6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617224552a70e8e6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2543082116","title":"Estrella Immunopharma, Inc.盤中異動 大幅拉昇6.25%報1.020美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543082116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543082116?lang=zh_tw&edition=fundamental","pubTime":"2025-06-16 21:47","pubTimestamp":1750081626,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时47分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨6.25%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616214706951ec6e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616214706951ec6e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2542510249","title":"Estrella Immunopharma, Inc.盤中異動 早盤股價大漲5.38%報1.050美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542510249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542510249?lang=zh_tw&edition=fundamental","pubTime":"2025-06-12 21:47","pubTimestamp":1749736070,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日21时47分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨5.38%。截至发稿，该股报1.050美元/股，成交量971股，换手率0.00%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。Estrella 的使命是利用人类免疫系统的进化力量来改变癌症和自身免疫性疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612214750977cb344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612214750977cb344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2542349415","title":"Estrella Immunopharma, Inc.盤中異動 股價大漲6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542349415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542349415?lang=zh_tw&edition=fundamental","pubTime":"2025-06-11 00:39","pubTimestamp":1749573579,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日00时39分，Estrella Immunopharma, Inc.股票出现异动，股价大幅拉升6.21%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大，Nucana Plc、Windtree Therapeutics, Inc.、Evogene Ltd.较为活跃，换手率分别为29468.33%、2779.61%、1329.02%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Klotho Neurosciences, Inc.，振幅分别为261.54%、191.40%、114.83%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506110039399779a151&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506110039399779a151&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2542338602","title":"Estrella Immunopharma, Inc.盤中異動 早盤大幅下挫5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542338602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542338602?lang=zh_tw&edition=fundamental","pubTime":"2025-06-09 21:59","pubTimestamp":1749477584,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时59分，Estrella Immunopharma, Inc.股票出现波动，股价快速下跌5.82%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609215945a700b795&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609215945a700b795&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2541286696","title":"Estrella Immunopharma, Inc.盤中異動 早盤股價大跌5.66%報1.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541286696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541286696?lang=zh_tw&edition=fundamental","pubTime":"2025-06-06 22:25","pubTimestamp":1749219903,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日22时25分，Estrella Immunopharma, Inc.股票出现异动，股价快速下跌5.66%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606222503a6fd564c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606222503a6fd564c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2541075915","title":"Estrella Immunopharma, Inc.盤中異動 早盤大幅下挫7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541075915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541075915?lang=zh_tw&edition=fundamental","pubTime":"2025-06-05 21:36","pubTimestamp":1749130597,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日21时36分，Estrella Immunopharma, Inc.股票出现异动，股价快速下跌7.06%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605213637a6fbd7d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605213637a6fbd7d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2540069027","title":"Estrella Immunopharma, Inc.盤中異動 早盤股價大漲5.49%報0.880美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540069027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540069027?lang=zh_tw&edition=fundamental","pubTime":"2025-06-04 21:36","pubTimestamp":1749044187,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日21时36分，Estrella Immunopharma, Inc.股票出现异动，股价急速拉升5.49%。截至发稿，该股报0.880美元/股，成交量7.9216万股，换手率0.22%，振幅2.59%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060421362797718e50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060421362797718e50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2540797410","title":"Estrella Immunopharma, Inc.盤中異動 下午盤快速跳水5.06%報0.959美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540797410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540797410?lang=zh_tw&edition=fundamental","pubTime":"2025-06-03 01:40","pubTimestamp":1748886056,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日01时40分，Estrella Immunopharma, Inc.股票出现波动，股价快速下跌5.06%。截至发稿，该股报0.959美元/股，成交量538股，换手率0.00%，振幅0.99%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.76%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603014057976eadf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603014057976eadf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2539261136","title":"Estrella Immunopharma, Inc.盤中異動 早盤快速上漲6.19%報1.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539261136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539261136?lang=zh_tw&edition=fundamental","pubTime":"2025-05-29 23:04","pubTimestamp":1748531070,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日23时04分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨6.19%。截至发稿，该股报1.030美元/股，成交量4567股，换手率0.01%，振幅5.15%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292304319769f634&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292304319769f634&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2537788934","title":"Estrella Immunopharma, Inc.盤中異動 早盤股價大漲6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537788934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537788934?lang=zh_tw&edition=fundamental","pubTime":"2025-05-21 22:55","pubTimestamp":1747839349,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日22时55分，Estrella Immunopharma, Inc.股票出现波动，股价快速拉升6.12%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521225549aa2c9573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521225549aa2c9573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2535315269","title":"Estrella Immunopharma, Inc.盤中異動 急速上漲6.37%報1.000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535315269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535315269?lang=zh_tw&edition=fundamental","pubTime":"2025-05-16 21:31","pubTimestamp":1747402269,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时31分，Estrella Immunopharma, Inc.股票出现波动，股价大幅拉升6.37%。截至发稿，该股报1.000美元/股，成交量782股，换手率0.00%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621310994f90e98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621310994f90e98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2535261618","title":"Estrella Immunopharma, Inc.盤中異動 早盤急速跳水5.05%報0.940美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535261618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535261618?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 21:38","pubTimestamp":1747316321,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时38分，Estrella Immunopharma, Inc.股票出现波动，股价急速跳水5.05%。截至发稿，该股报0.940美元/股，成交量347股，换手率0.00%，振幅0.25%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213841aa2c8fb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213841aa2c8fb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2535074407","title":"Estrella Immunopharma, Inc.盤中異動 急速下挫8.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535074407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535074407?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 23:24","pubTimestamp":1747236264,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日23时24分，Estrella Immunopharma, Inc.股票出现异动，股价快速下跌8.58%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.24%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514232424aa2c8ebb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514232424aa2c8ebb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2534241438","title":"Estrella Immunopharma, Inc.盤中異動 早盤股價大跌6.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534241438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534241438?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 21:41","pubTimestamp":1746798088,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时41分，Estrella Immunopharma, Inc.股票出现异动，股价快速下跌6.70%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921412894f1d720&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921412894f1d720&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2533935047","title":"Estrella Immunopharma, Inc.盤中異動 股價大漲5.43%報1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533935047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533935047?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 21:33","pubTimestamp":1746624798,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时33分，Estrella Immunopharma, Inc.股票出现异动，股价大幅拉升5.43%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213318a6d66b38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213318a6d66b38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":51,"code":"91000000","status":"200"}]}}